Literature DB >> 15120569

Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid.

Seigo Baba1, Naomi Osakabe, Midori Natsume, Junji Terao.   

Abstract

Rosmarinic acid (RA) is contained in various Lamiaceae herbs used commonly as culinary herbs. Although RA has various potent physiological actions, little is known on its bioavailability. We therefore investigated the absorption and metabolism of orally administered RA in rats. After being deprived of food for 12 h, RA (50 mg/kg body weight) or deionized water was administered orally to rats. Blood samples were collected from a cannula inserted in the femoral artery before and at designated time intervals after administration of RA. Urine excreted within 0 to 8 h and 8 to 18 h post-administration was also collected. RA and its related metabolites in plasma and urine were measured by LC-MS after treatment with sulfatase and/or beta-glucuronidase. RA, mono-methylated RA (methyl-RA) and m-coumaric acid (COA) were detected in plasma, with peak concentrations being reached at 0.5, 1 and 8 h after RA administration, respectively. RA, methyl-RA, caffeic acid (CAA), ferulic acid (FA) and COA were detected in urine after RA administration. These components in plasma and urine were present predominantly as conjugated forms such as glucuronide or sulfate. The percentage of the original oral dose of RA excreted in the urine within 18 h of administration as free and conjugated forms was 0.44 +/- 0.21% for RA, 1.60 +/- 0.74% for methyl-RA, 1.06 +/- 0.35% for CAA, 1.70 +/- 0.45% for FA and 0.67 +/- 0.29% for COA. Approximately 83% of the total amount of these metabolites was excreted in the period 8 to 18 h after RA administration. These results suggest that RA was absorbed and metabolized as conjugated and/or methylated forms, and that the majority of RA absorbed was degraded into conjugated and/or methylated forms of CAA, FA and COA before being excreted gradually in the urine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120569     DOI: 10.1016/j.lfs.2003.11.028

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Distinct substrate specificities and unusual substrate flexibilities of two hydroxycinnamoyltransferases, rosmarinic acid synthase and hydroxycinnamoyl-CoA:shikimate hydroxycinnamoyl-transferase, from Coleus blumei Benth.

Authors:  Marion Sander; Maike Petersen
Journal:  Planta       Date:  2011-02-12       Impact factor: 4.116

2.  Permeability of rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across Caco-2 cell monolayers.

Authors:  Zhiyi Qiang; Zhong Ye; Cathy Hauck; Patricia A Murphy; Joe-Ann McCoy; Mark P Widrlechner; Manju B Reddy; Suzanne Hendrich
Journal:  J Ethnopharmacol       Date:  2011-07-20       Impact factor: 4.360

3.  Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 Diabetes.

Authors:  Ling Wu; Paul Velander; Anne M Brown; Yao Wang; Dongmin Liu; David R Bevan; Shijun Zhang; Bin Xu
Journal:  ACS Pharmacol Transl Sci       Date:  2021-07-21

4.  Protection against LPS-induced cartilage inflammation and degradation provided by a biological extract of Mentha spicata.

Authors:  Wendy Pearson; Ronald S Fletcher; Laima S Kott; Mark B Hurtig
Journal:  BMC Complement Altern Med       Date:  2010-05-11       Impact factor: 3.659

5.  Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines.

Authors:  Kristen A Scheckel; Stephanie C Degner; Donato F Romagnolo
Journal:  J Nutr       Date:  2008-11       Impact factor: 4.798

6.  Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death.

Authors:  S Fallarini; G Miglio; T Paoletti; A Minassi; A Amoruso; C Bardelli; S Brunelleschi; G Lombardi
Journal:  Br J Pharmacol       Date:  2009-05-21       Impact factor: 8.739

7.  Effect of rosmarinic and caffeic acids on inflammatory and nociception process in rats.

Authors:  Giovana Duzzo Gamaro; Edna Suyenaga; Milene Borsoi; Joice Lermen; Patrícia Pereira; Patrícia Ardenghi
Journal:  ISRN Pharmacol       Date:  2011-03-30

8.  Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.

Authors:  Niloufar Ansari; Fariba Khodagholi
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

9.  Antileishmanial Phenylpropanoids from the Leaves of Hyptis pectinata (L.) Poit.

Authors:  Rosangela A Falcao; Patricia L A do Nascimento; Silvana A de Souza; Telma M G da Silva; Aline C de Queiroz; Carolina B B da Matta; Magna S A Moreira; Celso A Camara; Tania M S Silva
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-28       Impact factor: 2.629

10.  Systematic Analysis of Absorbed Anti-Inflammatory Constituents and Metabolites of Sarcandra glabra in Rat Plasma Using Ultra-High-Pressure Liquid Chromatography Coupled with Linear Trap Quadrupole Orbitrap Mass Spectrometry.

Authors:  Xiong Li; Jin Zhao; Jianxing Liu; Geng Li; Ya Zhao; Xing Zeng
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.